Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.
Clin. Cancer Res., Aug;10(15):4922-32 (2004)
Does laryngectomy improve swallowing after chemoradiotherapy? A case study.
Arch. Otolaryngol. Head Neck Surg., Jan;128(1):54-7 (2002)
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
J. Clin. Oncol., Jan;21(2):320-6 (2003)
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
Clin. Cancer Res., May;9(5):1689-97 (2003)
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
Clin. Cancer Res., Dec;9(16 Pt 1):5936-43 (2003)
Surgical variables affecting swallowing in patients treated for oral/oropharyngeal cancer.
Head Neck., Jul;26(7):625-36 (2004)